Advani, A., & Mughal, S. A. (2025). Luspatercept (REBLOZYL): A Game-Changer in Reducing Transfusion Burden for β-Thalassemia Patients. Innovative Research in Applied, Biological and Chemical Sciences, 3(1), 80-81. https://doi.org/10.62497/irabcs.150